1. Hepatitis C virus genotype 4-infection and interferon-free treatment in Egypt

   • Tatsuo Kanda
   • Shunichi Matsuoka
   • Mitsuhiko Moriyama

   Editorial 10 July 2018 Pages: 291 - 293

2. Depression, fatigue and neurocognitive deficits in chronic hepatitis C

   • Sern Wei Yeoh
   • Alex C. N. Holmes
   • Amanda J. Nicoll

   Review Article 21 June 2018 Pages: 294 - 304

   

3. Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cells

   • Muhammad Atif
   • Suz Warner
   • Ye H. Oo

   Review Article Open access 19 July 2018 Pages: 305 - 314

   

4. Global HBV burden: guesstimates and facts

   • Dina Ginzberg
   • Robert J. Wong
   • Robert Gish

   Review Article 27 July 2018 Pages: 315 - 329

   

5. Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis

   • Seogsong Jeong
   • Guijuan Luo
   • Qiang Xia

   Original Article 26 June 2018 Pages: 330 - 338

   

6. Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience

   • G. Shiha
   • R. Soliman
   • N. N. H. Mikhail

   Original Article 16 April 2018 Pages: 339 - 347

   

7. Efficacy and safety of sofosbuvir plus daclatasvir with or without ribavirin: large real-life results of patients with chronic hepatitis C genotype 4

   • Adel Abdel-Moneim
   • Alaa Aboud
   • Mohamed Ramadan

   Original Article 12 May 2018 Pages: 348 - 355

   

8. Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals

   • Namiki Izumi
   • Tetsuo Takehara
   • Masashi Mizokami

   Original Article Open access 20 July 2018 Pages: 356 - 367

   

9. Evaluation of liver function using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging based on a three-dimensional volumetric analysis system

   • Masashi Kudo
   • Naoto Gotohda
   • Ryuichi Hayashi

   Original Article Open access 02 June 2018 Pages: 368 - 376

   

10. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis

    • Rahima A. Bhanji
    • Carlos Moctezuma-Velazquez
    • Aldo J. Montano-Loza

    Original Article 07 June 2018 Pages: 377 - 386